ProQuad
measles, mumps, rubella and varicella vaccine (live)
Table of contents
Overview
ProQuad is a vaccine against measles, mumps, rubella, and varicella (chickenpox).
ProQuad is given to children from 12 months of age to help protect them against measles, mumps, rubella, and chickenpox. ProQuad may also be given to children from 9 months of age in certain situations, for example as part of a national vaccination programme, during an outbreak or for travel to a region where measles is common.
-
List item
ProQuad : EPAR - Medicine overview (PDF/135.22 KB)
First published: 02/06/2006
Last updated: 08/10/2020
EMA/433362/2020 -
-
List item
ProQuad : EPAR - Risk-management-plan summary (PDF/1.6 MB)
First published: 26/06/2020
Authorisation details
Product details | |
---|---|
Name |
ProQuad
|
Agency product number |
EMEA/H/C/000622
|
Active substance |
virus, live attenuated, measles, virus, live attenuated, mumps, virus, live attenuated, rubella, virus, live attenuated, varicella
|
International non-proprietary name (INN) or common name |
measles, mumps, rubella and varicella vaccine (live)
|
Therapeutic area (MeSH) |
|
Anatomical therapeutic chemical (ATC) code |
J07BD54
|
Publication details | |
---|---|
Marketing-authorisation holder |
Merck Sharp & Dohme B.V.
|
Revision |
31
|
Date of issue of marketing authorisation valid throughout the European Union |
05/04/2006
|
Contact address |
Waarderweg 39 |
Product information
21/07/2022 ProQuad - EMEA/H/C/000622 - IA/0159/G
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
Vaccines
Therapeutic indication
ProQuad is indicated for simultaneous vaccination against measles, mumps, rubella and varicella in individuals from 12 months of age.
ProQuad can be administered to individuals from 9 months of age under special circumstances (e.g., to conform with national vaccination schedules, outbreak situations, or travel to a region with high prevalence of measles.